Migraine in physicians and final year medical students: A cross-sectional insight into prevalence, self-awareness, and knowledge from Pakistan

Table 2 Results of analysis between groups based on consult-seeking behaviors and migraine diagnoses

	Consultation seeking			Migraine
	Non-consulters (n = 109)	Consulters (n = 66)	P	Migraineurs (n = 48)	Non-migraineurs (n = 127)	P
Gender	Females: 54 (49.5%); Males: 55 (50.5%)	Females: 34 (51.5%); Males: 32 (48.5%)	0.8	Females: 28 (58.3%); Males: 20 (41.7%)	Females: 60 (47.2%); Males: 67 (52.7%)	0.19
Knowledge of diagnostic criteria	Remember: 37 (33.9%); Don’t remember:72 (66.1%)	Remember: 29 (43.9%); Don’t remember: 37 (56.1%)	0.24	Remember: 25 (52.1%); Don’t remember: 23 (47.9%)	Remember: 41 (32.3%); Don’t remember: 86 (67.7%)	0.016; OR: 2.26 (95% CI: 1.1-4.5)
Know prophylaxis indications	Yes: 31 (28.4%); No:78 (71.6%)	Yes: 38 (34.9%); No: 28 (42.4%)	0.05	Yes: 21 (43.7%); No: 27 (56.2%)	Yes: 38 (29.9%); No: 89 (70.1%)	0.08
Aura essential for diagnosis?	Yes: 65 (59.6%); No or not sure: 44(40.4%)1	Yes: 27 (40.9%); No or not sure: 39 (51.1%)1	0.016; OR: 0.47 (95%CI: 0.25-0.87)	Yes: 22 (45.8%); No or not sure: 26 (54.2%)	Yes: 70 (55.1%); No or not Sure: 57 (44.9%)	0.27
Consulted		Neurologist: 10 (15.2%); Other doctor(s): 56 (84.8%); None: 0 (0%)		Neurologist:8 (16.7%); Other doctors:21 (43.7%); None: 19 (39.6%)	Neurologist: 2 (1.6%); Other doctors: 35 (27.6%); None: 90 (70.9%)	< 0.001
Monthly attack cutoff for prophylaxis2	Correctly Identified: 33 (30.3%); Could not Identify: 75 (68.8%)	Correctly Identified: 10 (15.1%); Could not Identify: 56 (84.9%)	0.02	Correctly Identified: 16; Could not Identify: 32	Correctly Identified: 27 (21.4%); Could not Identify: 99 (78.6%)	0.11
Know correct duration of prophylaxis?3	Yes: 28 (25.7%); No: 81 (74.3%)	Yes :20 (30.3%); No: 46 (69.7%)	0.5	Yes: 13 (27%); No: 35 (73%)	Yes: 35 (27.5%); No: 92 (72.5%)	0.94
Frequency of headache attacks (per month)	None: 31 (28.4%); ≤ 1: 39(35.8%); 2: 17 (15.6%); 3: 6 (5.5%); ≥ 4: 16 (14.7%)	None: 13 (19.7%); ≤ 1: 22 (33.3%); 2: 13 (19.7%); 3: 8 (12.1%); ≥ 4: 10 (15.1%)	0.4	None: 4 (8.3%); ≤ 1: 16 (33.3%); 2: 9 (18.7%); 3: 6 (12.5%); ≥ 4: 13 (27.1%)	None: 40 (31.5%); ≤ 1: 45 (35.4%); 2: 21 (15.7%); 3: 8 (6.3%); ≥ 4: 13 (2.4%)1	< 0.01
Total triggers recognized	Median: 4, IQR: 5	Median: 3, IQR: 4	0.29	Median: 3.5, IQR: 3	Median: 4, IQR: 5	0.297
Total indications recognized	Median: 2, IQR: 1	Median: 1, IQR: 1	0.21	Median: 1, IQR: 1	Median: 1, IQR: 1	0.22
Distractor(s) recognized as triggers	Yes: 47 (43.1%); No: 62 (56.9%)	Yes: 29 (43.9%); No: 37 (56.1%)	0.91	Yes: 22 (45.8%); No: 26 (54.2%)	Yes: 54 (42.5%); No: 73 (57.5%)	0.69
Distractor(s) recognized as Indications	Yes: 37 (33.9%); No: 71 (65.1%)	Yes: 17 (25.7%); No: 49 (74.2%)	0.23	Yes: 16 (33.3%); No: 32 (66.7%)	Yes: 38 (22.1%); No: 88 (87.9%)	0.68
Migraineurs	Migraineurs: 19 (17.4%); Non-migraineurs: 90 (82.5%)1	Migraineurs: 29 (43.9%); Non-migraineurs: 37 (56.1%)1	< 0.001; OR: 3.7 (95%CI: 1.8-7.5)

¹Indicates statistically significant results.

²Monthly headache rate ≥ 4 was chosen as standard for initiation of prophylaxis according to American Headache Society (AHS) guidelines.

³A 6-mo duration of prophylaxis was chosen as standard according to AHS guidelines.

IQR: Inter-quartile range; OR: Odd’s ratio; CI: Confidence interval.